Earnings ·
OPKO Health, Inc. reported second quarter 2026 financial results, with consolidated total revenues of $163.5 million…
OPKOpko Health, Inc.
OPKO Health, Inc. reported second quarter 2026 financial results, with consolidated total revenues of $163.5 million compared to $156.8 million in the prior year period. The company's operating loss for the second quarter was $7.0 million, an improvement from a $60.0 million operating loss in the same period in 2025. Net loss per share of $0.01 per share was reported for the second quarter. OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company focused on delivering next-generation solutions for serious diseases across global markets.